Free

Q&A - The Past, Present and Future of Breast Cancer Research

Event Information

Share this event

Date and Time

Location

Location

Art Gallery of New South Wales

Art Gallery Rd

Sydney, NSW 2000

Australia

View Map

Event description

Description

More than 18,000 women will be diagnosed with breast cancer in Australia this year and 3,000 women in New Zealand – that’s 58 women every day. In fact, breast cancer is the leading cause of death from cancer in women aged 25-49 years in Australia.

While we have come a long way with improved breast cancer survival rates and falling mortality figures, particularly over the last 20 years, we still have a long way to go to find a treatment and prevention strategy for every woman and her unique circumstance.

Breast Cancer Trials (BCT) is the largest, independent, oncology clinical trials research group in Australia and New Zealand. Since our inception in 1978, we have been committed to finding new and improved breast cancer treatments and prevention strategies for every woman, through the conduct of breast cancer clinical trials research.

As one of the most successful, respected and oldest breast cancer research groups in the world, our research program has played a pivotal role in influencing and improving treatments and care in Australia, New Zealand and globally. The results of our research has changed practice and saved millions of lives through international collaborative research.

As part of activities to recognise our 40th anniversary in 2018 and on the eve of our Annual Scientific Meeting for researchers, Breast Cancer Trials will be hosting a Q&A event at The Art Gallery of NSW, to discuss The Past, Present and Future of Breast Cancer Research.

Moderated by Journalist and Channel 10 presenter Sandra Sully, the Q&A will feature a panel of breast cancer experts and trial participants, to discuss and answer questions about the history of our research group, key milestones in breast cancer research and clinical trials, current research trends and developments, and what can we expect in breast cancer research in the future.


Our panelists are:

Professor Alan Coates AM - one of the Founders of BCT and President of the Clinical Oncological Society of Australia in 1994 and 1995. From 1998 – 2006 he was Chief Executive Officer of The Cancer Council Australia. He was the first elected non-US member of the Board of Directors of the American Society of Clinical Oncology. He was Chairman of the BCT Scientific Advisory Committee from 1985 - 2005 and was co-Chairman of the Scientific Committee of the International Breast Cancer Study Group until 2015. His research interests include clinical trials in breast cancer and melanoma, and studies of quality of life in cancer patients. Awards include Member of the Order of Australia (AM) in 2002 for “service to medicine in the field of oncology, particularly through breast cancer research”, the Medical Oncology Group of Australia Pierre Fabre Cancer Achievement Award in 2003, and in 2006 the ASCO Distinguished Service Award for Scientific Leadership, the Gold Medal of the Australian Cancer Society, the Tom Reeve Oration Award of the Clinical Oncological Society of Australia and the BCT Gold Medal.

Professor Fran Boyle AM - was elected to the BCT Board of Directors in 2001 and was Chair of the Board from July 2012 to July 2015. Professor Boyle Chaired the BCT Scientific Advisory Committee for five years until November 2010. She is a Medical Oncologist and is Professor of Medical Oncology at the University of Sydney and Director of the Patricia Richie Centre for Cancer Care and Research at the Mater Hospital, Sydney, and represents BCT on the International Breast Cancer Study Group Foundation Council. She has close links with health professionals across the spectrum of cancer care and with the medical teaching program of the University of Sydney, and is a Board Director with the Breast Cancer Network of Australia. Professor Boyle was honoured in 2008 with Membership of the Order of Australia for work with professionals and community organisations involved in cancer care and research.

Ms Leslie Gilham - is a member and the incoming Chair of the BCT Consumer Advisory Panel. Leslie has a personal and family history of breast cancer. She was diagnosed with breast cancer in 2009 and participated in the TEXT clinical trial as part of her treatment regime. She is also an advocate and consumer representative for the Breast Cancer Network of Australia.

Associate Professor Nicholas Wilcken - was elected to the BCT Board of Directors in July 2016 and was the Study Chair of the HERA clinical trial. He was the Chair of the BCT’s Scientific Advisory Committee from 2011 to March 2017. Associate Professor Wilcken is the Director of Medical Oncology at the Crown Princess Mary Cancer Centre Westmead, Senior Staff Specialist at Nepean Hospital and Associate Professor of Medicine at the University of Sydney. His clinical interests are mainly in breast cancer and his research interests include translational oncology, systematic reviews and breast cancer clinical trials. He is currently the Co-ordinating Editor of the Cochrane Collaboration’s Breast Cancer Group. He has been an invited expert panel member for previous St Gallen Early Breast Cancer Consensus Conferences in Switzerland and is a member of the Steering Committee of the Early Breast Cancer Trialists’ Collaborative Group, based in Oxford, UK.

Associate Professor Prue Francis - is the Chair of the BCT Scientific Advisory Committee and Study Chair of the SOFT and TEXT clinical trials. She is Clinical Head of Breast Medical Oncology at the Peter MacCallum Cancer Centre in Melbourne and also a consultant Medical Oncologist at St Vincent’s Hospital Melbourne. She holds an academic appointment at The University of Melbourne. Associate Professor Francis graduated from The University of Melbourne and completed medical oncology training in Melbourne and at Memorial Sloan Kettering Cancer Centre in New York. She holds an appointment as Conjoint Associate Professor at The University of Newcastle in the School of Medicine and Public Health. She is a member of the Scientific Committee of the International Breast Cancer Study Group (IBCSG).

Professor Cristin Print - graduated in Medicine from the University of Auckland in 1989 and began research while working as a house surgeon in Dunedin, NZ. An immunology PhD at the University of Auckland led to a four-year postdoctoral period in the Walter and Eliza Hall Institute in Melbourne, Australia. He used transgenic technologies to research apoptosis in Melbourne, Australia, before moving to Cambridge University, UK, for six years where he was a Fellow of St Edmunds College and developed a deep interest in genomics and bioinformatics. He co-founded a public genomics and bioinformatics company in Japan before returning to New Zealand in 2005 where he has been using genomics to better understand human pathology, with special focus on cancer. He leads the Genomics Into Medicine Strategic Research Initiative in Auckland and Chairs the Auckland Regional Tissue Bank Scientific Advisory Board. He is currently a Professor in the University's Department of Molecular Medicine and Pathology, a Principal Investigator in the Maurice Wilkins Centre, on the Science Leadership Team of the Healthier Lives National Science Challenge, Chair of Scientific Advisory Board of the Auckland Regional Tissue Bank Vice President of the Auckland Museum Institute and on the Board of NZ’s Institute of Environmental Science and Research. He is past Director of the NZ Bioinformatics Institute and immediate past President of the New Zealand Society for Oncology.


About the Q&A

This event is free to attend but registration is required to secure your seats. When registering for the event, attendees may submit a question or topic that they would like answered or discussed on the night. The event will be broadcast live on Facebook.

For more information about Breast Cancer Trials, visit www.breastcancertrials.org.au

Share with friends

Date and Time

Location

Art Gallery of New South Wales

Art Gallery Rd

Sydney, NSW 2000

Australia

View Map

Save This Event

Event Saved